Dr. Belkoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Presidential Blvd
Ste 100
Bala Cynwyd, PA 19004Phone+1 610-667-3020Fax+1 610-667-1817
Summary
- Dr. Laurence Belkoff is an urologist in Bala Cynwyd, PA and is affiliated with multiple hospitals in the area, including Lankenau Medical Center. He received his medical degree from Kansas City University/ College of Osteopathic Medicine and has been in practice 35 years. He id the Program Director for the Main Line Health System Urology Residency. He id the Director of Research for Solaris Health and MidLantic Urology. He specializes in General Urology and is experienced in overactive bladder, prostate cancer, and impotence. He has more than 100 publications and over 200 citings.He has bee Principal Investigator for more than 200 clinical trials.
Education & Training
- Philadelphia College of Osteopathic MedicineL.D., 2002
- Albert Einstein Healthcare NetworkResidency, Urology, 1984 - 1987
- Philadelphia College of Osteopathic MedicineMSc, Urologic Surgery, 1987
- Beaumont Health (Farmington Hills)Internship, Transitional Year, 1982 - 1983
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1982
- Emory UniversityB.A., 1974 - 1978
Certifications & Licensure
- PA State License 1984 - 2026
- NJ State License 1996 - 2025
- WV State License 1983 - 1986
- MI State License 1983 - 1984
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- President's Special Recognition Award ACOS, 1999
- Second Place, Resident Essay Contest POMA, 1987
- Join now to see all
Clinical Trials
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsDeep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patient...Fred Saad, Maha H A Hussain, Bertrand Tombal, Karim Fizazi, Cora N Sternberg
European Urology. 2024-10-01 - 14 citationsSelective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancerEvan Y. Yu, Robert H. Getzenberg, Christopher C. Coss, Marc M. Gittelman, Thomas E. Keane
European Urology. 2015-02-01 - 4 citationsA Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer.Jose De La Cerda, Curtis Dunshee, Lawrence Gervasi, Paul Sieber, Laurence Belkoff
Targeted Oncology. 2023-05-01
Journal Articles
- Long Term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Castration-Resistant Protstate ...Laurence H. Beelkoff, DO, Clinical Cancer Research, 11/1/2013
- An Open Label, Long Term Evaulation of the Safety, Efficiacy, and Tolerability of Avanafil in Male Patients with Mild to Severe Erectile DysfunctionLaurence H. Beelkoff, DO, The International Journal of Clinical Practice, 4/1/2013
- Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double Blind Study in Men with Diabetes MellitusLaurence H. Beelkoff, DO, Mayo Clinic Proceedings, 9/1/2012
- Join now to see all
Abstracts/Posters
- Tasquinimod and improved survival in men with metastatic castration-resistant prostate cancer: Results of long term follow up of a randomized phase 2 placebo-controlle...Laurence H. Beelkoff, DO, ASCO Annual Meeting, 6/1/2012
- Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men with Diabetes Mellitus.Laurence H. Beelkoff, DO, Mayo ClinProc, World Meeting on Sexual Medicine, Chicago, IL, August 26-30, 2012, 1/1/2012
- Patients Improve When Switching from Finasteride to Dutasteride.Laurence H. Beelkoff, DO, American College of Osteopathic Surgeons, American Urological Association, Atlanta, GA; Washington, DC, May 2011, 9/1/2011
- Join now to see all
Lectures
- Urology Grand Rounds: "Overview of Clinical Research in a Urologic Practice"Philadelphia College of Osteopathic Medicine - 12/1/2013
- "The ERa Agonist, GTx-758, Results in a Significantly Lower Rate of Hot Flashes and Bone Turnover in Comparison to Leuprolide in Men with Advanced Prostate Cancer"San Diego, CA - 5/7/2013
- "The ABC's of Clinical Research in a Urologic Practice"9/17/2011
- Join now to see all
Press Mentions
- Former Philly Mayor Michael Nutter Had Surgery for Prostate Cancer. He Especially Wants Black Men to Hear About His ExperienceJune 8th, 2021
- How Hahnemann's Urology Residents Found a New Home on the Main LineJanuary 14th, 2020
- A Guy’s Guide to Sexual HealthJanuary 10th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: